posted on 2025-11-17, 12:44authored byHans Clevers, Ankur Sharma, Sendurai A Mani, Anna Golebiewska, Axel Behrens, Wai Leong Tam, Loic P Deleyrolle, Huiping Liu, Karuna Ganesh, Walid T Khaled, Shaheen Sikandar, Terence K Lee, Tyler E Miller, Dean G Tang, Sheila Singh, Vivian SW Li, Justin D Lathia, Stephanie Ma
The inaugural FASEB Science Research Conference (SRC) on Cellular Plasticity in Cancer was held in May 2025 in Hong Kong SAR, China. This event brought together leading experts to discuss cutting-edge research centered on cancer cell plasticity. The conference featured comprehensive presentations covering a broad spectrum of topics, including oncofetal reprogramming in tumor development and progression, mechanisms regulating cancer cell plasticity, metabolic reprogramming and its role in tumor progression, cancer cell plasticity during metastasis, cancer stem cell programs within the tumor microenvironment, tumor plasticity and immune evasion, as well as innovative therapeutic strategies aimed at targeting stem cell-like states, modulating cancer cell states, and effectively controlling disease progression. It is anticipated that the insights gained from this meeting will catalyze further advancements in cancer biology and therapy.
Funding
NCI NIH HHS (Grant ID: R01 CA240290)
Crick (Grant ID: CC2141, Grant title: Li CC2141)